Aller au contenu principal
Profil bibliographique

Ottavia Clemente

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

40Publications signalées
320Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Sarcoma Diagnosis and TreatmentNeuroendocrine Tumor Research AdvancesLung Cancer Research StudiesLung Cancer Treatments and MutationsChronic Myeloid Leukemia Treatments

Les publications récentes

Accès ouvert 2026 dataset OpenAlex

Raw data supporting "Peptide Optimization to Improve Antigen Presentation and Antitumor Responses in Sarcoma"

Angela Mauriello, Concetta Ragone, Beatrice Cavalluzzo, AnnaLucia Tornesello et autres

This dataset contains the raw and processed data supporting the results presented in the article “Peptide Optimization to Improve Antigen Presentation and Antitumor Responses in Sarcoma”. The deposited data include computational HLA-A*02:01 peptide-binding predictions, experimental T2-cell peptide-binding and stability assays, IFN-γ ELISpot …

it (code pays fourni par la source)

0 citations Zenodo (CERN European Organization for Nuclear Research)
Accès ouvert 2026 dataset OpenAlex

Raw data supporting "Peptide Optimization to Improve Antigen Presentation and Antitumor Responses in Sarcoma"

Angela Mauriello, Concetta Ragone, Beatrice Cavalluzzo, AnnaLucia Tornesello et autres

This dataset contains the raw and processed data supporting the results presented in the article “Peptide Optimization to Improve Antigen Presentation and Antitumor Responses in Sarcoma”. The deposited data include computational HLA-A*02:01 peptide-binding predictions, experimental T2-cell peptide-binding and stability assays, IFN-γ ELISpot …

it (code pays fourni par la source)

0 citations Zenodo (CERN European Organization for Nuclear Research)
Accès ouvert 2026 article OpenAlex

Systems Serology Identifies Differential Pan-viral Seroreactivity Profiles Associated with Healthy Aging and Cancer

Beatrice Cavalluzzo, Biancamaria Cembrola, Simona Mangano, Andrea Belli et autres

A viral exposure signature (VES) has previously been shown to predict the development of hepatocellular carcinoma (HCC) in at-risk individuals through comprehensive serological profiling using the VirScan platform. Whether cumulative antimicrobial immune histories are associated with cancer status across multiple malignancies remains …

it, us (code pays fourni par la source)

0 citations Zenodo (CERN European Organization for Nuclear Research)
Accès ouvert 2026 article OpenAlex

Systems Serology Identifies Differential Pan-viral Seroreactivity Profiles Associated with Healthy Aging and Cancer

Beatrice Cavalluzzo, Biancamaria Cembrola, Simona Mangano, Andrea Belli et autres

A viral exposure signature (VES) has previously been shown to predict the development of hepatocellular carcinoma (HCC) in at-risk individuals through comprehensive serological profiling using the VirScan platform. Whether cumulative antimicrobial immune histories are associated with cancer status across multiple malignancies remains …

it, us (code pays fourni par la source)

0 citations Zenodo (CERN European Organization for Nuclear Research)
2026 preprint OpenAlex

Differential serum binding patterns predicting healthy subjects and cancer patients

Beatrice Cavalluzzo, Biancamaria Cambrola, Simona Mangano, Andrea Belli et autres

Abstract A viral exposure signature (VES) has been previously described predicting the development of Hepatocellular carcinoma (HCC) in at-risk patients. This has been achieved by a serological profiling of the viral infection history using a synthetic human virome including >100k epitopes (VirScan). …

it, my, us (code pays fourni par la source)

1 citation bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2026 article OpenAlex

Cabozantinib and temozolomide in patients with advanced progressive neuroendocrine tumors: a phase 2 study

Mauro Cives, Giuseppina Della Vittoria Scarpati, Ottavia Clemente, Eleonora Lauricella et autres

Treatment options for patients with advanced neuroendocrine tumors (NETs) are limited. Preclinical and early clinical evidence suggest that cabozantinib and temozolomide may exert synergistic antitumor activity. We performed an open-label, single-arm, phase 2 study (NCT04893785) to assess the safety and efficacy of …

it (code pays fourni par la source)

1 citation Nature Communications
Accès ouvert 2026 review OpenAlex

A systematic review and meta-analysis of pazopanib efficacy and adverse effects in sarcomas

Fernanda Picozzi, Antonella Lucia Marretta, Mariachiara Santorsola, L. Cannella et autres

BACKGROUND: Pazopanib, a multi-targeted tyrosine kinase inhibitor, is employed in the treatment of various malignancies, including metastatic non-adipocytic soft tissue sarcoma. METHODS: This systematic review and meta-analysis adhered to PRISMA guidelines to evaluate the efficacy and toxicity of pazopanib monotherapy in treating …

it (code pays fourni par la source)

1 citation Journal of Translational Medicine
Accès ouvert 2026 review OpenAlex

A systematic review and meta-analysis of pazopanib efficacy and adverse effects in sarcomas

F. Picozzi, Alessandro Ottaiano, Antonella Lucia Marretta, Mariachiara Santorsola et autres

Abstract Background Pazopanib, a multi-targeted tyrosine kinase inhibitor, is employed in the treatment of various malignancies, including metastatic non-adipocytic soft tissue sarcoma. Methods This systematic review and meta-analysis adhered to PRISMA guidelines to evaluate the efficacy and toxicity of pazopanib monotherapy in …

it (code pays fourni par la source)

0 citations Figshare
Accès ouvert 2026 review OpenAlex

A systematic review and meta-analysis of pazopanib efficacy and adverse effects in sarcomas

F. Picozzi, Alessandro Ottaiano, Antonella Lucia Marretta, Mariachiara Santorsola et autres

Abstract Background Pazopanib, a multi-targeted tyrosine kinase inhibitor, is employed in the treatment of various malignancies, including metastatic non-adipocytic soft tissue sarcoma. Methods This systematic review and meta-analysis adhered to PRISMA guidelines to evaluate the efficacy and toxicity of pazopanib monotherapy in …

it (code pays fourni par la source)

0 citations Figshare

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.